(CVRX)
0.00
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
0.00
0.00 (0.00%)
CVRx, Inc., tijoriy bosqichdagi tibbiy qurilmalar kompaniyasi, Qo'shma Shtatlar, Germaniya va xalqaro miqyosda yurak-qon tomir kasalliklari bo'lgan bemorlar uchun neyromodulyatsiya yechimlarini ishlab chiqish, ishlab chiqarish va tijoratlashtirish bilan shug'ullanadi. Kompaniya Barostimni taklif etadi, bu implantatsiya qilinadigan qurilma bo'lib, u karotid arteriya devorida joylashgan baroreseptorlarga elektr impulslarini etkazib beradi, bu esa baroreseptor signallarining pasayishiga qarshi turadi va barorefleks aktivatsiya terapiyasini ta'minlaydi, bu esa yurak-qon tomir tizimini avtonom nerv sistemasiga bog'laydi. Mahsulotlarini to'g'ridan-to'g'ri sotish bo'limi, savdo agentlari va mustaqil distribyutorlar orqali sotadi. Kompaniya 2000 yilda tashkil etilgan va shtab-kvartirasi Minneapolis, Minnesota shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Philip B. Adamson M.D., M.Sc. | Chief Medical Officer |
| Mr. Brent Binkowski | Chief Operating Officer |
| Mr. Gregory Morrison | Chief Human Resources Officer |
| Mr. Jared Oasheim | Chief Financial Officer |
| Mr. Kevin Hykes | President, CEO & Director |
| Mr. Paul Verrastro | Chief Marketing & Strategy Officer |
| Mr. Robert Allen John | Chief Revenue Officer |
| Ms. Bonnie Handke M.B.A., R.N. |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-03 | 8-K | tm267672d1_8k.htm |
| 2025-11-17 | DEL AM | tm2531452d1_delam.htm |
| 2025-11-06 | 10-Q | cvrx-20250930x10q.htm |
| 2025-11-05 | 8-K | tm2530302d1_8k.htm |
| 2025-08-05 | 10-Q | cvrx-20250630x10q.htm |
| 2025-08-04 | 8-K | tm2522379d1_8k.htm |
| 2025-06-05 | 8-K | tm2517167d1_8k.htm |
| 2025-05-23 | SD | tm2515710d1_sd.htm |
| 2025-05-09 | 10-Q | cvrx-20250331x10q.htm |
| 2025-05-08 | 8-K | tm2514410d1_8k.htm |
| Senior Vice President of Patient Access, Reimbursement, & Healthcare Economics |
| Ms. Jonelle R. Burnham | VP & General Counsel |